Records 1 - 30
| The role of ERBB4 mutations in the prognosis of advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
Molecular medicine (Cambridge, Mass.) 2021 Oct 27 (1): 126.
Hu Xilin, Xu Hanlin, Xue Qianwen, Wen Ruran, Jiao Wenjie, Tian Kaih
| Co-mutations of epidermal growth factor receptor and BRAF in Chinese non-small cell lung cancer patients.
Annals of translational medicine 2021 Aug 9 (16): 1321.
Peng Panli, Lv Guoli, Hu Jinwei, Wang Kai, Lv Junhong, Guo Ga
| Genomic alteration profiles of lung cancer and their relationship to clinical features and prognosis value using individualized genetic testing.
Journal of thoracic disease 2021 Aug 13 (8): 5007-5015.
Zhang Fan, Wang Junyan, Ma Minting, Xu Yu, Lu Xiangjun, Wei Su
| PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort.
Clinical lung cancer 2021 Aug .
Jin Yan, Xue Qianqian, Shen Xuxia, Zheng Qiang, Chen Haiquan, Zhou Xiaoyan, Li Yu
| Driver and novel genes correlated with metastasis of non-small cell lung cancer: A comprehensive analysis.
Pathology, research and practice 2021 Jul 224 153551.
Wu Yongfeng, Ni Heng, Yang Dexin, Niu Yuequn, Chen Kelie, Xu Jinming, Wang Fang, Tang Song, Shi Yu, Zhang Honghe, Hu Jian, Xia Dajing, Wu Yih
| Retrospective analysis of eleven gene mutations, PD-L1 expression and clinicopathological characteristics in non-small cell lung cancer patients.
Asian journal of surgery 2021 Jul .
Liu Yanqing, Wu Aihua, Li Xinjian, Wang Shanshan, Fang Shuyu, Mo Yij
| Integration of clinicopathological and mutational data offers insight into lung cancer with tumor spread through air spaces.
Annals of translational medicine 2021 Jun 9 (12): 985.
Tian Yu, Feng Jing, Jiang Long, Ning Junwei, Gu Zenan, Huang Jia, Luo Qingqu
| Landscape of IDH1/2 mutations in Chinese patients with solid tumors: A pan-cancer analysis.
Molecular genetics & genomic medicine 2021 Jun e1697.
Shen Dong, Zhang Junling, Yuan Kai, Zhao Jing, Zhao Zhengyi, Cui Longgang, Zhang Yuzi, Wang Guoqiang, Cai Shangli, Bai Yuezong, Li Wei, Huang Xia
| Next-generation sequencing of tissue and circulating tumor DNA: Resistance mechanisms to EGFR targeted therapy in a cohort of patients with advanced non-small cell lung cancer.
Cancer medicine 2021 Jun .
Zhang Yujun, Xiong Liwen, Xie Fangfang, Zheng Xiaoxuan, Li Ying, Zhu Lei, Sun Jiayu
| TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib.
Translational oncology 2021 Jun 14 (9): 101163.
Yu Ruofei, Bai Hua, Li Tangai, Gao Bingyu, Han Jiefei, Chang Geyun, Zhang Pei, Fei Kailun, He Xiran, Wang J
| Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).
Lung cancer (Amsterdam, Netherlands) 2021 May .
Wislez Marie, Domblides Charlotte, Greillier Laurent, Mazières Julien, Monnet Isabelle, Kiakouama-Maleka Lize, Quantin Xavier, Spano Jean Philippe, Ricordel Charles, Fraisse Philippe, Janicot Henri, Audigier-Valette Clarisse, Amour Elodie, Langlais Alexandra, Rabbe Nathalie, Makinson Alain, Cadranel Jacques, Laurent-Puig Pierre, Lavolé Armelle, Blons Hélè
| Distinct mutational backgrounds and clonal architectures implicated prognostic discrepancies in small-cell carcinomas of the esophagus and lung.
Cell death & disease 2021 May 12 (5): 472.
Song Zhengbo, Liu Yueping, Cheng Guoping, Chang Lianpeng, Yu Zicheng, Chen Ming, Chen Ga
| NGS-based liquid biopsy profiling identifies mechanisms of resistance to ALK inhibitors: a step toward personalized NSCLC treatment.
Molecular oncology 2021 May .
Sánchez-Herrero Estela, Serna-Blasco Roberto, Ivanchuk Vadym, García-Campelo Rosario, Dómine Gómez Manuel, Miguel Sánchez José, Massutí Bartomeu, Reguart Noemi, Camps Carlos, Sanz-Moreno Sandra, Calabuig-Fariñas Silvia, Jantus-Lewintre Eloísa, Arnal Magdalena, Fernández-Orth Dietmar, Calvo Virginia, González-Rumayor Víctor, Provencio Mariano, Romero Atoc
| Cell-Free Circulating Tumor DNA Improves Standard Genotyping of Non-Small-Cell Lung Cancer and Increases Detection of Targetable Alterations in a Selected Hispanic Cohort.
Oncology 2021 Apr 1-8.
Zatarain-Barrón Zyanya Lucia, Cardona Andrés F, Díaz-García Diego, Trejo Rosales Rogelio, Rojas Leonardo, Cruz-Rico Graciela, Nagy Rebecca, Cabrera Luis, Vargas Carlos, Saam Jennifer, Barrón Feliciano, Arrieta Osc
| Integration of comprehensive genomic profiling, tumor mutational burden, and PD-L1 expression to identify novel biomarkers of immunotherapy in non-small cell lung cancer.
Cancer medicine 2021 Apr 10 (7): 2216-2231.
Shi Yunfei, Lei Youming, Liu Li, Zhang Shiyue, Wang Wenjing, Zhao Juan, Zhao Songhui, Dong Xiaowei, Yao Ming, Wang Kai, Zhou Qi
| The Association of Aging-Related Polymorphisms with Susceptibility to Lung Cancer: A Case-Control Study in a Japanese Population.
Asian Pacific journal of cancer prevention : APJCP 2021 Apr 22 (4): 1279-1285.
Furuie Hironobu, Arimura-Omori Masako, Hamada Naoki, Yanagihara Toyoshi, Kiyohara Chika
| The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients.
International journal of cancer 2021 Apr .
Cai Lei, Chen Yong, Tong Xiaoling, Wu Xue, Bao Hua, Shao Yang, Luo Zhuang, Wang Xuming, Cao Ya
| Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective study.
Lung cancer (Amsterdam, Netherlands) 2021 Mar 155 20-27.
Wang Wenxian, Xu Chunwei, Chen Huafei, Jia Jinhao, Wang Liping, Feng Huijing, Wang Hong, Song Zhengbo, Yang Nong, Zhang Yongcha
| Comprehensive genomic profiling of combined small cell lung cancer.
Translational lung cancer research 2021 Feb 10 (2): 636-650.
Zhang Jing, Zhang Liping, Luo Jie, Ge Tao, Fan Pengyu, Sun Liangdong, Hou Likun, Li Junqiang, Yu Huansha, Wu Chunxiao, Zhu Yuming, Wu Chunyan, Jiang Gening, Troncone Giancarlo, Malhotra Jyoti, Okuda Katsuhiro, Santarpia Mariacarmela, Zamarchi Rita, Goto Taichiro, Cardona Andrés F, Xu Jianfang, Chen Qiankun, Zhang Zhonghong, Zhang Peng,
| Genetic alterations in squamous cell lung cancer associated with idiopathic pulmonary fibrosis.
International journal of cancer 2021 Feb .
Hata Atsushi, Nakajima Takahiro, Matsusaka Keisuke, Fukuyo Masaki, Nakayama Manabu, Morimoto Junichi, Ito Yuki, Yamamoto Takayoshi, Sakairi Yuichi, Rahmutulla Bahityar, Ota Satoshi, Wada Hironobu, Suzuki Hidemi, Iwata Takekazu, Matsubara Hisahiro, Ohara Osamu, Yoshino Ichiro, Kaneda Atsus
| PTEN Loss as a Predictor of Tumor Heterogeneity and Poor Prognosis in Patients With EGFR-mutant Advanced Non-small-cell Lung Cancer Receiving Tyrosine Kinase Inhibitors.
Clinical lung cancer 2021 Feb .
Ferrara Miriam Grazia, Martini Maurizio, D'Argento Ettore, Forcella Chiara, Vita Emanuele, Di Noia Vincenzo, Sperduti Isabella, Bilotta Mirna, Ribelli Marta, Damiano Paola, Cannella Antonella, Stefani Alessio, Pilotto Sara, Carbone Carmine, Piro Geny, Milella Michele, Tortora Giampaolo, Bria Emil
| Genomic profiling of extracellular vesicle-derived DNA from bronchoalveolar lavage fluid of patients with lung adenocarcinoma.
Translational lung cancer research 2021 Jan 10 (1): 104-116.
Lee Seung Eun, Park Ha Young, Hur Jae Young, Kim Hee Joung, Kim In Ae, Kim Wan Seop, Lee Kye You
| Mutation profile of non-small cell lung cancer revealed by next generation sequencing.
Respiratory research 2021 Jan 22 (1): 3.
Chang Ya-Sian, Tu Siang-Jyun, Chen Yu-Chia, Liu Ting-Yuan, Lee Ya-Ting, Yen Ju-Chen, Fang Hsin-Yuan, Chang Jan-Gow
| Role of next generation sequencing-based liquid biopsy in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: impact of STK11, KRAS and TP53 mutations and co-mutations on outcome.
Translational lung cancer research 2021 Jan 10 (1): 202-220.
Pavan Alberto, Bragadin Andrea Boscolo, Calvetti Lorenzo, Ferro Alessandra, Zulato Elisabetta, Attili Ilaria, Nardo Giorgia, Dal Maso Alessandro, Frega Stefano, Menin Andrea Giovanni, Fassan Matteo, Calabrese Fiorella, Pasello Giulia, Guarneri Valentina, Aprile Giuseppe, Conte PierFranco, Rosell Rafael, Indraccolo Stefano, Bonanno Lau
| De Novo Versus Secondary Metastatic EGFR-Mutated Non-Small-Cell Lung Cancer.
Frontiers in oncology 2021 11 640048.
Bozorgmehr Farastuk, Kazdal Daniel, Chung Inn, Kirchner Martina, Magios Nikolaus, Kriegsmann Mark, Allgäuer Michael, Klotz Laura V, Muley Thomas, El Shafie Rami A, Fischer Jürgen R, Faehling Martin, Stenzinger Albrecht, Thomas Michael, Christopoulos Petr
| Prevalence of TP-53/Rb-1 Co-Mutation in Large Cell Neuroendocrine Carcinoma.
Frontiers in oncology 2021 11 653153.
Saghaeiannejad Esfahani Hoda, Vela Cory M, Chauhan Am
| The Prevalence and Concurrent Pathogenic Mutations of KRAS in Northeast Chinese Non-small-cell Lung Cancer Patients.
Cancer management and research 2021 13 2447-2454.
Liu Yan, Li Hui, Zhu Jing, Zhang Yang, Liu Xianhong, Li Rixin, Zhang Qiang, Cheng Yi
| Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China.
Frontiers in oncology 2021 11 630717.
Lv Weize, Cheng Hua, Shao Di, Wei Yajun, Zhu Weiping, Wu Kui, Jiang Wenxi, Hu Liyang, Sha Zhou, Zhong Beilong, Pei Xiaofe
| Predictive values of genomic variation, tumor mutational burden, and PD-L1 expression in advanced lung squamous cell carcinoma treated with immunotherapy.
Translational lung cancer research 2020 Dec 9 (6): 2367-2379.
Xu Yanjun, Li Hui, Huang Zhiyu, Chen Kaiyan, Yu Xiaoqing, Sheng Jiamin, Zhang Han-Han, Fan Y
| Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer.
Journal of oncology 2020 2020 8811487.
Chen Dongfang, Xu Jianlin, Qiao Rong, Zhao Yizhuo, Chu Tianqing, Han Baohui, Zhong Run